Study of diagnostic and prognostic parameters in Breast cancer patients without metastasis

Aqsa Neelam, Ahmad Ali, Rabail Alam, Ghulam Mujtaba, Imran Riaz Malik

Abstract


Background: Carcinoma of the breast is the most prevalent cause of mortality from cancer in women aged 40-69 years. The aim of the present study was to examine any alteration in the status of lactate dehydrogenase, ferritin, gamma glutamyl transferase, Platelets, hemoglobin, alkaline phosphatase, aspartate transaminase, alanine transferase and bilirubin in the plasma of breast cancer patients without distant metastasis, to establish their diagnostic and prognostic values.

Methods: Current reading describes a study conducted on 50 breast cancer patients from Institute of Nuclear Medicine and Oncology (Lahore). The patients were clinically categorized as stage II (19 patients) and stage III (29 patients) respectively. Most of the patients were diseased with infiltrative ductal carcinoma (48) of the breast. Blood samples of all patients were collected after forty days of chemotherapy course besides 10 healthy subjects.

Results: There was a significant rise in LDH (221.48 ± 18.44) and Ferritin (356.46 ± 12.28) levels as compared to control groups. Concentration of GGT (34.12 ± 1.61) was also elevated but not significantly raised. There was no significant rise in ALP (279.27 ± 26.60), AST (49.44 ± 8.510), ALT (33.40 ± 2.83), bilirubin (4.87 ± 3.96), Hb (11.16 ± .299) and platelets (032.54 ± 21.68) levels in comparison to normal control subjects. An elevation of LDH and ferritin levels in cases of carcinoma breast signifies its importance as a biomarker of disease. A serial measurement of these enzymes would have diagnostic and prognostic significance and help treatment decisions.

Conclusion: The ferritin along with lactate dehydrogenase can be used as a valuable biomarker for breast cancer diagnosis and prognosis.

Keywords: Breast cancer; Prognostic parameters; Treatment; Metastasis


Full Text:

PDF

References


nuradha A. Liver function analysis in patients with carcinoma breast under radiotherapy. Journal of Medical and Allied Sciences, (2012); 2; 1-11.

Baloch AH, Shuja J, Daud S, Ahmed M, Ahmad A, et al. Various aspects, patterns and risk factors in breast cancer patients of Balochistan. Asian Pacific Journal of Cancer Prevention, (2012); 13(8): 4013-4016.

Boehm DU, Lebrecht A, Schmidt M, Siggelkow W, Lindner C, et al. Prognostic impact of haemoglobin levels in breast cancer. Anticancer research, (2007); 27(2): 1223-1226.

Cao R, Wang LP. Serological diagnosis of liver metastasis in patients with breast cancer. Cancer biology & medicine, (2012); 9(1): 57.

Chandrakanth KH. Study of serum levels of gamma-glutamyl transferase, lactate dehydrogenase, malondialdehyde and vitamin E in breast cancer. International journal of Pharma and Biosciences, (2011); 2(4): 489-498.

Cujic D, Stefanoska I, Golubovic S. Serum ferritin in healthy women and breast cancer patients. Journal of Medical Biochemistry, (2011); 30(1): 33-37.

Duffy MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Medical Principles and Practice, (2013); 22(1): 4-11.

Fentiman IS, Allen DS. γ-Glutamyl transferase and breast cancer risk. British journal of cancer, (2010); 103(1): 90-93.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer, (2010); 127(12): 2893-2917.

Hajizadeh E, Abdollahi M, Baghestani AR, Haghighat S. Prognostic Cut Point for Breast Cancer Age of Diagnosis. International Journal of Cancer Management, (2018); 11(5). e9291.

Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY. Serum ferritin concentration in early breast cancer. British journal of cancer, (1976); 34(3): 286-290.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians, (2011); 61(2): 69-90.

Khan MO. The necessity of awareness of breast cancer amongst women in Pakistan. JPMA. The Journal of the Pakistan Medical Association, (2009); 59(11): 804.

Mishra S, Sharma DC, Sharma P. Studies of biochemical parameters in breast cancer with and without metastasis. Indian Journal of Clinical Biochemistry, (2004); 19(1): 71-75.

Seth RK, Kharb S, Kharb DP. Serum biochemical markers in carcinoma breast. Indian journal of medical sciences, (2003); 57(8): 350-354.

Tang C, Wang P, Li X, Zhao B, Yang H, et al. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis. PloS one, 2017; 12(8).

Veni GK, Rao DB, Kumar DM, Usha B, Krishna VM, Rao TR. Clinical evaluation of oxidative stress in women with breast cancer. Recent Research in Science and Technology, (2011); 3(1): 55-58.




DOI: http://dx.doi.org/10.62940/als.v7i3.958

Refbacks

  • There are currently no refbacks.